Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of FACBC in High-Risk Prostate Cancer
NCT03081884Phase 2Completed
- Sponsor
- Emory University
- Start
- Mar 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluciclovine f 18 in prostate cancer (PCa), sponsored by Emory University. Started Mar 2017; status: completed.
02
Drugs
fluciclovine f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03081884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03081884.